ABC | Volume 114, Nº1, January 2019

Short Editorial Bittencourt Estimating cardiovascular risk in HIV-infected patients Arq Bras Cardiol. 2020; 114(1):76-77 1. Hemkens LG, Bucher HC. HIV infection and cardiovascular disease. Eur Heart J. 2014;35(21):1373-81. 2. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiencyvirusdisease.JClinEndocrinolMetab.2007;92(7):2506-12. 3. DubeMP. Disorders of glucosemetabolism in patients infectedwith human immunodeficiency virus. Clin Infect Dis.2000;31(6):1467-75. 4. Friis-Moller N, RyomL, Smith C, Weber R, Reiss P, Dabis F, et al. An updated predictionmodel of the global risk of cardiovascular disease inHIV-positive persons: The Data-collection on Adverse Effects of Anti-HIVDrugs (D:A:D) study. Eur J Prev Cardiol. 2016;23(2):214-23. 5. Boccara F, Lang S, Meuleman C, Ederhy S, Mary-Krause M, Costagliola D, et al. HIV and coronary heart disease: time for a better understanding. J Am Coll Cardiol. 2013;61(5):511-23. 6. Wilson PW, D’Agostino RB, LevyD, Belanger AM, SilbershatzH, KannelWB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-47. 7. Silva AG, Paulo RV, Silva-VergaraML. Subclinical carotid atherosclerosis and reduced DAD Score for Cardiovascular Risk Stratification in HIV - Positive Patients. Arq Bras Cardiol. 2020; 114(1):68-75. References This is an open-access article distributed under the terms of the Creative Commons Attribution License 77